Rater agreement and utility of the mutagen-induced chromosome damage assay

Anticancer Research

Volumn 21, Issue 1 B, 2001, Pages 605-609

  McIntyre, L M ^a   O'Briant, K C ^a   McBride, C M ^a   Bepler, G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Bleomycin induced chromosomal lesions; Bleomycin induced chromosome damage; Cancer phenotype assay; Cancer susceptibility assay; Lung cancer; Mutagen sensitivity assay

Indexed keywords

BLEOMYCIN; CARCINOGEN; CYTOTOXIC AGENT; MUTAGENIC AGENT;

ARTICLE; ASSAY; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMATID; CHROMOSOME DAMAGE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM CANCER; HEALTH CARE COST; HUMAN; IN VITRO STUDY; LUNG CANCER; METAPHASE; MUTAGEN TESTING; OBSERVER VARIATION; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RELIABILITY; RISK ASSESSMENT;

BLEOMYCIN; CELLS, CULTURED; CHROMATIDS; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN; DRUG RESISTANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES; LUNG NEOPLASMS; MUTAGENICITY TESTS; OBSERVER VARIATION; ODDS RATIO; RISK ASSESSMENT; TRANSLOCATION, GENETIC;

EID: 0035065140     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cancer statistics, 2000
2. Revisions in the international system for staging lung cancer
3. Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis
4. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans
5. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer
6. Benzo[a]pyrene dioal epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer
7. A parallel study of in vitro sensitivity, to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls
8. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract
9. Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members
10. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers
11. Mutagen sensitivity in upper aerodigestive tract cancer: A case-control analysis
12. In vitro preventive effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients
13. Mutagen sensitivity in patients with head and neck cancers: A biological marker for risk of multiple primary malignancies
14. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases
15. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk
16. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay
17. Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients
18. Establishment and identification of small cell lung cancer cell lines having classic and variant features
19. Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines
20. Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer
21. Multiple chromosomal aberrations and chromosome 11p allelotyping in lung cancer cell lines
22. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer
23. A 1.4-Mb high-resolution physical map and contig of chromosome segment 11p15.5 and genes in the LOH11A metastasis suppressor region
24. Lung cancer epidemiology and genetics
25. Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit